Clinical trial
Glargine Insulin Versus Continous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)
NCT02216799 is registered in ClinicalTrials.gov with King Faisal Specialist Hospital & Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glargine Insulin Versus Continous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)
- Lead sponsor
- King Faisal Specialist Hospital & Research Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- August 31, 2015
- Enrollment
- 61 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic patients with gastrointestinal cancer undergoing surgery and receiving parenteral nutrition